W
RMD icon

Wealthfront’s ResMed RMD Stock Holding History

Wealthfront’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$630K Sell
5,465
-329
-6% -$36K 0.01% 347
2018
Q2 		$600K Buy
5,794
+3,139
+118% +$318K 0.01% 341
2018
Q1 		$261K Buy
2,655
+261
+11% +$24.7K ﹤0.01% 461
2017
Q4 		$203K Buy
+2,394
New +$198K ﹤0.01% 496
2016
Q4 		– Sell
-3,536
Closed -$229K – 397
2016
Q3 		$229K Buy
+3,536
New +$235K 0.01% 340
2015
Q4 		– Sell
-626
Closed -$32K – 880
2015
Q3 		$32K Buy
626
+317
+103% +$17.1K ﹤0.01% 609
2015
Q2 		$17K Sell
309
-110
-26% -$6.94K ﹤0.01% 686
2015
Q1 		$30K Buy
419
+414
+8,280% +$26.9K ﹤0.01% 518
2014
Q4 		$0 Buy
+5
New +$261 ﹤0.01% 922

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthfront's RMD Position: Q3 2018 in Review

Wealthfront reduced its ResMed (RMD) stake by 5.7% in Q3 2018, selling an estimated $36K and leaving 5,465 shares worth $630K. The position accounts for 0.01% of the portfolio, ranked #347.

Wealthfront first reported a position in RMD in Q4 2014 and has held it in 9 quarters since. 498 funds tracked by Wall St. Rank hold RMD as of Q3 2018.

  • Wealthfront held 5,465 shares of ResMed worth $630K as of Q3 2018.
  • Wealthfront sold 329 ResMed shares in Q3 2018, an estimated $36K.
  • ResMed made up 0.01% of Wealthfront's portfolio in Q3 2018, its #347 holding.
  • Wealthfront first reported a position in ResMed in Q4 2014 and has held it in 9 quarters since.
  • 498 funds tracked by Wall St. Rank held ResMed as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.